Ticker > IPO > upcoming > Macleods Pharmaceuticals Ltd.

IPO

Macleods Pharmaceuticals Ltd.

It is pharmaceutical company, engaged in developing, manufacturing, and marketing a wide range of formulations across several major therapeutic areas including antiinfectives, cardiovascular, anti-diabetic, dermatology, and hormone treatment.

RHP
View
DRHP
View
Open Date

Not Issued

Close Date

Not Issued

IPO Details

Check out the issue details for Macleods Pharmaceuticals Ltd. IPO as disclosed in SEBI.

Price Band

Not Issued

Issue Size

Not Issued

Issue Type

Book Built

Open

Not Issued

Close

Not Issued

News

 IPO news not found.

Company Financials

You can get the following financial statements of Macleods Pharmaceuticals Ltd. as of now.

  Profit Loss
  Balance Sheet
  Quarterly
  Shareholding
  Cash Flow

Subscription Details

Macleods Pharmaceuticals IPO Valuation

The approx valuation of Macleods Pharmaceuticals IPO company based on its price band and DRHP (prospectus) is: 

Particulars Value
Upper Price Band Rs __
Existing Shares (Qty) 59.88 Cr
EPS (FY21) Rs 33.74
Industry PE 32.53x

 

Macleods Pharmaceuticals IPO Issue Size

Macleods Pharmaceuticals IPO issue size is not disclosed. 

Issue Amount
Fresh Issue 0 Cr
Offer For Sale (Qty) 6.04 Cr

 

Macleods Pharmaceuticals IPO Market Lot

An Individual can apply for a minimum 1 lot of _ shares and a maximum of 13 lots of _ shares. Find the details below:

Application Lot Shares Amount
 Minimum  1 _ Rs _
 Maximum 13 _ Rs _

 

Macleods Pharmaceuticals IPO share offer

The category-wise shares offered are as follows:

Category % Offered
Qualified Institutional Maximum 50%
Non-Institutional Minimum 15%
Retail Individual Minimum 35%

 

Allotment Details

The dates for the IPO is not been disclosed. 

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Net Sales 5505.51 6076.16 6590.5 7014.11 7462.67
Total Expenditure 4352.5 4736.76 4686.17 4670.54 5903.67
Operating Profit 1153 1339.4 1904.32 2343.56 1559
Other Income 78.78 223.12 329.95 544.64 126.2
Interest 4.33 8.27 19.15 5.84 10.81
Depreciation 80.77 90.21 94.63 132.13 156.55
Exceptional Items 0 0 0 0 0
Profit Before Tax 1146.69 1464.04 2120.5 2750.23 1517.84
Provision for Tax 77.58 182.32 265.26 533.91 350.61
Net Profit 1069.11 1281.73 1855.24 2216.33 1167.23
Adjusted EPS (Rs.) 1.79 2.14 3.1 3.7 1.95

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Equity and Liabilities
Share Capital 19.96 19.96 19.96 19.96 59.88
Total Reserves 4894.68 6257.37 8072.73 4226.69 5353.38
Borrowings 7.68 0 31.82 0 0
Other N/C liabilities 195.86 213.54 223.38 -356.33 -298.23
Current liabilities 943.15 882.89 1048.58 1428.64 1324.91
Total Liabilities 6061.34 7373.77 9396.47 5318.96 6439.94
Assets
Net Block 1063.23 1074.44 1245.48 1399.64 1473.42
Capital WIP 26.83 51.15 213.55 252.75 334.34
Intangible WIP 0 0 0 0 0
Investments 2315.11 1111.59 1168.58 16.93 234.76
Loans & Advances 41.72 32.68 33.36 123.88 89.94
Other N/C Assets 107.96 297.27 2104.22 220.6 771.75
Current Assets 2506.48 4806.63 4631.28 3305.17 3535.73
Total Assets 6061.34 7373.77 9396.47 5318.96 6439.94
* Other Non-current Liabilities include Net deferred Liabilities

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2021 100 0
Mar 2020 100 0
* Figures given above are % of equity capital

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Profit from operations 1146.69 1464.04 2120.5 2750.23 1517.84
Adjustment 47.18 -97.81 -117.42 -343 112.96
Changes in Assets & Liabilities -374.86 -214.9 -690.96 -654.3 94.45
Tax Paid -248.46 -383.09 -351.93 -477.54 -314.77
Operating Cash Flow 570.56 768.25 960.18 1275.39 1410.47
Investing Cash Flow -839.01 -747.57 -661.95 -1330.74 -1399.39
Financing Cash Flow -4.33 -40.02 -115.51 30.46 -21.12
Net Cash Flow -272.78 -19.34 182.71 -24.89 -10.04
X